Contact
Please use this form to send email to PR contact of this press release:
Corbus Pharmaceuticals Announces Last Patient Enrolled in Phase 2 Study of Resunab for Systemic Sclerosis
TO:
Please use this form to send email to PR contact of this press release:
Corbus Pharmaceuticals Announces Last Patient Enrolled in Phase 2 Study of Resunab for Systemic Sclerosis
TO: